Zobrazeno 1 - 10
of 19 314
pro vyhledávání: ''
Autor:
Jordi Remon, Benjamin Lacas, Roy Herbst, Martin Reck, Edward B. Garon, Giorgio V. Scagliotti, Rodryg Ramlau, Nasser Hanna, Johan Vansteenkiste, Kiyotaka Yoh, Harry J.M. Groen, John V. Heymach, Sumithra J. Mandrekar, Isamu Okamoto, Joel W. Neal, Rebecca S. Heist, David Planchard, Jean-Pierre Pignon, Benjamin Besse, B. Besse, B. Lacas, J.P. Pignon, J. Remon, T. Berghmans, S. Dahlberg, E. Felip, Thierry Berghmans, Suzanne Dahlberg, Enriqueta Felip, Edward Garon, Alex A. Adjei, Rebecca Heist
Publikováno v:
European Journal of Cancer. 166:112-125
BACKGROUND: Now that immunotherapy plus chemotherapy (CT) is one standard option in first-line treatment of advanced non-small cell lung cancer (NSCLC), there exists a medical need to assess the efficacy of second-line treatments (2LT) with antiangio
Autor:
Paul E. Wakely
Publikováno v:
Cancer Cytopathology. 130:595-608
Although usually recognized as malignant, fine-needle aspiration (FNA) biopsy of salivary duct carcinoma (SDC) has been confused with other primary salivary gland (SG) neoplasms. This article undertook an analysis of a large collection of SDC FNA cas
Autor:
Nobuki, Furubayashi, Futoshi, Morokuma, Toshihisa, Tomoda, Yoshifumi, Hori, Takahito, Negishi, Akihiro, Miura, Hiroki, Komori, Kentaro, Kuroiwa, Motonobu, Nakamura
Publikováno v:
Anticancer Research. 42:1571-1577
The optimal timing of switching from platinum-based chemotherapy to pembrolizumab in patients with advanced urothelial carcinoma (UC) remains unclear.Thirty-four patients who received pembrolizumab as second-line treatment after first-line platinum-b
Autor:
KAZUKI HASHIMOTO, RYUJI YASUMATSU, RYOSUKE KUGA, TAKAHIRO HONGO, HIDETAKA YAMAMOTO, MIOKO MATSUO, TAKAHIRO WAKASAKI, RINA JIROMARU, TOMOMI MANAKO, SATOSHI TOH, MUNEYUKI MASUDA, MORIYASU YAMAUCHI, YUICHIRO KURATOMI, HIDEOKI URYU, TORAHIKO NAKASHIMA, AKIHIRO TAMAE, RISA TANAKA, MASAHIKO TAURA, TORANOSHIN TAKEUCHI, TAKAMASA YOSHIDA, TAKASHI NAKAGAWA
Publikováno v:
Anticancer Research. 42:981-989
The efficacy of programmed cell death 1 (PD-1) inhibitor therapy for patients with recurrent and/or metastatic salivary gland carcinoma (R/M SGC) remains unclear.We retrospectively analyzed 36 patients with R/M SGC treated with PD-1 inhibitor. The ex
Publikováno v:
Anticancer Research. 42:1001-1006
Formation of stoma during cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis (PC) is often performed to reduce the risk of anastomotic leak. Subsequent stoma reversal provides a unique oppo
Autor:
Stefanie D. Krens, Wim van Boxtel, Carla M.L. van Herpen, Sasja F. Mulder, Frank G A Jansman, Maike J. M. Uijen, Ingrid M.E. Desar, Nielka P. van Erp
Publikováno v:
International Journal of Cancer, 150, 308-316
International Journal of Cancer, 150, 2, pp. 308-316
International Journal of Cancer, 150(2), 308-316. Wiley
International Journal of Cancer, 150, 2, pp. 308-316
International Journal of Cancer, 150(2), 308-316. Wiley
Contains fulltext : 249093.pdf (Publisher’s version ) (Open Access) Cabozantinib is registered in fixed 60 mg dose. However, 46% to 62% of patients in the registration studies needed a dose reduction due to toxicity. Improved clinical efficacy has
Autor:
Ghlichloo, Ida, Jin, Zhongbo, Fan, Ruohao, Tong, Caili, Starostik, Petr, Chien, Jeremy R, Lai, Jinping
Publikováno v:
In Vivo
In vivo (Athens, Greece), vol 36, iss 1
In vivo (Athens, Greece), vol 36, iss 1
Background/Aim: It is estimated that nonmelanoma skin cancer (NMSC), including basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), affects more than 3 million Americans each year. Translation of next-generation sequencing (NGS) data into id
Autor:
Hiroko Yamashita, Kanako C. Hatanaka, Toraji Amano, Yoshihiro Matsuno, Yutaka Hatanaka, Kanako Hagio
Publikováno v:
Breast, Vol 60, Iss, Pp 206-213 (2021)
The Breast : Official Journal of the European Society of Mastology
The Breast : Official Journal of the European Society of Mastology
Background Because a number of years may be required for normal cells to develop into carcinoma, genes involved in tumorigenesis and progression might differ among breast cancers in young women and those in older women. The present study sought to an
Autor:
Tawfiqul Bhuiya, Juan P. Idrovo, Jin Cao, Pooja Navale, Louis J. Auguste, Sudarshana Roychoudhury, Silvat Sheikh-Fayyaz, Hua Guo
Publikováno v:
Clinical Breast Cancer. 21:e638-e646
This study explored human papillomavirus (HPV) amplification in breast benign and malignant lesions by chromogenic in situ hybridization (CISH) and the concordance of p16 expression by immunohistochemistry.The presence of HPV6/11 and HPV16/18 in 33 c
Autor:
Jörg Kaiser, Markus W. Büchler, Kazufumi Honda, Hien Dang, Takashi Kobayashi, Niall Brindl, Matthias M. Gaida, Keiko Takeuchi, Ayumi Kashiro, O. Strobel, Sascha Hinterkopf, Kengo Nagashima, Klaus Felix
Publikováno v:
International Journal of Cancer. 150:881-894
Intraductal papillary mucinous neoplasms (IPMNs) are premalignant lesions of pancreatic cancer. An accurate serum biomarker, which allows earlier identification of asymptomatic individuals with high-risk for developing cancer, is of urgent need. Apol